IL7Rα contributes to experimental autoimmune encephalomyelitis through altered t cell responses and nonhematopoietic cell lineages

Journal of Immunology

Volumn 190, Issue 9, 2013, Pages 4525-4534

  Ashbaugh, Jessica J ^a   Brambilla, Roberta ^a   Karmally, Shaffiat A ^a   Cabello, Cecilia ^a   Malek, Thomas R ^a   Bethea, John R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7 RECEPTOR ALPHA; NEUTRALIZING ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; HEMATOPOIETIC CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; THYMUS; WILD TYPE;

ANIMALS; ASTROCYTES; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MUTATION; MYELIN SHEATH; OLIGODENDROGLIA; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTES; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876801098     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203214     Document Type: Article

References (71)

1. Perry, V. H., and D. C. Anthony. 1999. Axon damage and repair in multiple sclerosis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354: 1641-1647. (Pubitemid 29534431)
2. Lassmann, H., W. Brück, and C. F. Lucchinetti. 2007. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17: 210-218. (Pubitemid 46466140)
3. Trapp, B. D., and K. A. Nave. 2008. Multiple sclerosis: an immune or neuro-degenerative disorder? Annu. Rev. Neurosci. 31: 247-269.
4. Trapp, B. D., J. Peterson, R. M. Ransohoff, R. Rudick, S. Mörk, and L. Bö. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338: 278-285. (Pubitemid 28065253)
5. Flügel, A., T. Berkowicz, T. Ritter, M. Labeur, D. E. Jenne, Z. Li, J. W. Ellwart, M. Willem, H. Lassmann, and H. Wekerle. 2001. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14: 547-560. (Pubitemid 32520866)
6. Issazadeh, S., M. Mustafa, A. Ljungdahl, B. Höjeberg, A. Dagerlind, R. Elde, and T. Olsson. 1995. Interferon g, interleukin 4 and transforming growth factor b in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 40: 579-590.
7. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747. (Pubitemid 40563183)
8. Steinman, L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
9. Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune de-myelination. J. Exp. Med. 193: 427-434. (Pubitemid 32524474)
10. Brambilla, R., J. J. Ashbaugh, R. Magliozzi, A. Dellarole, S. Karmally, D. E. Szymkowski, and J. R. Bethea. 2011. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 134(Pt. 9): 2736-2754.
11. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93: 7861-7864. (Pubitemid 26277129)
12. Cathala, F., and P. Brown. 1972. The possible viral aetiology of disseminated sclerosis. J. Clin. Pathol. Suppl. (R Coll Pathol) 6: 141-151.
13. Haire, M., K. B. Fraser, and J. H. Millar. 1973. Measles and other virus-specific immunoglobulins in multiple sclerosis. BMJ 3: 612-615.
14. Winer, S., I. Astsaturov, R. K. Cheung, K. Schrade, L. Gunaratnam, D. D. Wood, M. A. Moscarello, P. O'Connor, C. McKerlie, D. J. Becker, and H. M. Dosch. 2001. T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice. J. Immunol. 166: 4751-4756. (Pubitemid 32233764)
15. Elian, M., and G. Dean. 1987. Multiple sclerosis among the United Kingdomborn children of immigrants from the West Indies. J. Neurol. Neurosurg. Psychiatry 50: 327-332. (Pubitemid 17025874)
16. Miller, D. H., S. R. Hammond, J. G. McLeod, G. Purdie, and D. C. Skegg. 1990. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J. Neurol. Neurosurg. Psychiatry 53: 903-905. (Pubitemid 20351058)
17. Hoffjan, S., and D. A. Akkad. 2010. The genetics of multiple sclerosis: an update 2010. Mol. Cell. Probes 24: 237-243.
18. International Multiple Sclerosis Genetics Consortium, D. A. Hafler, A. Compston, S. Sawcer, E. S. Lander, M. J. Daly, P. L. De Jager, P. I. de Bakker, S. B. Gabriel, D. B. Mirel, et al;. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357: 851-862. (Pubitemid 47347319)
19. Aulchenko, Y. S., I. A. Hoppenbrouwers, S. V. Ramagopalan, L. Broer, N. Jafari, J. Hillert, J. Link, W. Lundström, E. Greiner, A. Dessa Sadovnick, et al. 2008. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat. Genet. 40: 1402-1403.
20. Comabella, M., D. W. Craig, M. Camiña-Tato, C. Morcillo, C. Lopez, A. Navarro, J. Rio; BiomarkerMS Study Group, , X. Montalban, and R. Martin. 2008. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500, 000 single nucleotide polymorphisms. PLoS One 3: e3490.
21. Baranzini, S. E., N. W. Galwey, J. Wang, P. Khankhanian, R. Lindberg, D. Pelletier, W. Wu, B. M. Uitdehaag, L. Kappos, C. H. Polman, et al. 2009. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet. 18: 2078-2090.
22. Australia and New Zealand Multiple Sclerosis Genetics Consortium. 2009. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 41: 824-828.
23. Jakkula, E., V. Leppä, A. M. Sulonen, T. Varilo, S. Kallio, A. Kemppinen, S. Purcell, K. Koivisto, P. Tienari, M. L. Sumelahti, et al. 2010. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 86: 285-291.
24. Zaffaroni, M., M. Di Falco, A. Ghezzi, L. Rizzolo, G. Veneroni, and S. Marforio. 1988. HLA typing and T-cell subpopulations in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 51: 1465.
25. Gregory, S. G., S. Schmidt, P. Seth, J. R. Oksenberg, J. Hart, A. Prokop, S. J. Caillier, M. Ban, A. Goris, L. F. Barcellos, et al. 2007. Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 39: 1083-1091. (Pubitemid 47340652)
26. Zuvich, R. L., J. L. McCauley, J. R. Oksenberg, S. J. Sawcer, P. L. De Jager, C. Aubin, A. H. Cross, L. Piccio, N. T. Aggarwal, D. Evans, et al. 2010. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum. Genet. 127: 525-535.
27. Lundmark, F., K. Duvefelt, E. Iacobaeus, I. Kockum, E. Wallström, M. Khademi, A. Oturai, L. P. Ryder, J. Saarela, H. F. Harbo, et al. 2007. Variation in inter-leukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39: 1108-1113. (Pubitemid 47340654)
28. O'Doherty, C., O. Kantarci, and K. Vandenbroeck. 2008. IL7RA polymorphisms and susceptibility to multiple sclerosis. N. Engl. J. Med. 358: 753-754. (Pubitemid 351240775)
29. Goodwin, R. G., D. Friend, S. F. Ziegler, R. Jerzy, B. A. Falk, S. Gimpel, D. Cosman, S. K. Dower, C. J. March, A. E. Namen, et al. 1990. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60: 941-951.
30. Ramanathan, M., B. Weinstock-Guttman, L. T. Nguyen, D. Badgett, C. Miller, K. Patrick, C. Brownscheidle, and L. Jacobs. 2001. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116: 213-219. (Pubitemid 32588634)
31. Lee, L. F., R. Axtell, G. H. Tu, K. Logronio, J. Dilley, J. Yu, M. Rickert, B. Han, W. Evering, M. G. Walker, et al. 2011. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-b in multiple sclerosis. Sci. Transl. Med. 3: 93ra68.
32. Liu, X., S. Leung, C. Wang, Z. Tan, J. Wang, T. B. Guo, L. Fang, Y. Zhao, B. Wan, X. Qin, et al. 2010. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat. Med. 16: 191-197.
33. Akashi, K., M. Kondo, and I. L. Weissman. 1998. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol. Rev. 165: 13-28. (Pubitemid 28524199)
34. Porter, B. O., P. Scibelli, and T. R. Malek. 2001. Control of T cell development in vivo by subdomains within the IL-7 receptor a-chain cytoplasmic tail. J. Immunol. 166: 262-269. (Pubitemid 32038441)
35. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737. (Pubitemid 32678096)
36. Seddon, B., P. Tomlinson, and R. Zamoyska. 2003. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 4: 680-686. (Pubitemid 36874445)
37. + T cells. Nat. Immunol. 10: 149-157.
38. Michaelson, M. D., M. F. Mehler, H. Xu, R. E. Gross, and J. A. Kessler. 1996. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev. Biol. 179: 251-263. (Pubitemid 26363261)
39. Nunnari, G., Y. Xu, E. A. Acheampong, J. Fang, R. Daniel, C. Zhang, H. Zhang, M. Mukhtar, and R. J. Pomerantz. 2005. Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection. J. Neurovirol. 11: 319-328. (Pubitemid 41614511)
40. Kremlev, S. G., A. L. Gaurnier-Hausser, L. Del Valle, G. Perez-Liz, S. Dimitrov, and G. Tuszynski. 2008. Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis. J. Neuroimmunol. 194: 132-142.
41. + memory T cells. Eur. J. Immunol. 37: 3078-3088. (Pubitemid 350131287)
42. Brambilla, R., T. Persaud, X. Hu, S. Karmally, V. I. Shestopalov, G. Dvoriantchikova, D. Ivanov, L. Nathanson, S. R. Barnum, and J. R. Bethea. 2009. Transgenic inhibition of astroglial NF-kB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182: 2628-2640.
43. Szalai, A. J., S. Nataf, X. Z. Hu, and S. R. Barnum. 2002. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol. 168: 5792-5797. (Pubitemid 34556165)
44. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150: 580-596. (Pubitemid 9250687)
45. Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky, B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180: 1955-1960.
46. Maraskovsky, E., M. Teepe, P. J. Morrissey, S. Braddy, R. E. Miller, D. H. Lynch, and J. J. Peschon. 1996. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J. Immunol. 157: 5315-5323. (Pubitemid 126448949)
47. Bernard, C. C, J. Leydon, and I. R. Mackay. 1976. T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. 6: 655-660.
48. Ortiz-Ortiz, L., R. M. Nakamura, and W. O. Weigle. 1976. T cell requirement for experimental allergic encephalomyelitis induction in the rat. J. Immunol. 117: 576-579.
49. Nagasawa, T. 2006. Microenvironmental niches in the bone marrow required for B-cell development. Nat. Rev. Immunol. 6: 107-116. (Pubitemid 43361586)
50. Mann, M. K., A. Ray, S. Basu, C. L. Karp, and B. N. Dittel. 2012. Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity 45: 388-399.
51. Hjelmström, P., A. E. Juedes, J. Fjell, and N. H. Ruddle. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161: 4480-4483. (Pubitemid 28492015)
52. Rochman, Y., M. Kashyap, G. W. Robinson, K. Sakamoto, J. Gomez-Rodriguez, K. U. Wagner, and W. J. Leonard. 2010. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc. Natl. Acad Sci. USA 107: 19455-19460.
53. Pandey, A., K. Ozaki, H. Baumann, S. D. Levin, A. Puel, A. G. Farr, S. F Ziegler, W. J. Leonard, and H. F Lodish. 2000. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 1: 59-64.
54. Park, L. S., U. Martin, K. Garka, B. Gliniak, J. P. Di Santo, W Muller, D. A. Largaespada, N. G. Copeland, N. A. Jenkins, A. G. Farr, et al. 2000. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 192: 659-670.
55. Miyajima, A., S. Miyatake, J. Schreurs, J. De Vries, N. Arai, T. Yokota, and K. Arai. 1988. Coordinate regulation of immune and inflammatory responses by T cell-derived lymphokines. FASEB J. 2: 2462-2473.
56. Murphy, A. C, S. J. Lalor, M. A. Lynch, and K. H. Mills. 2010. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 24: 641-651.
57. Dus, D., A. Krawczenko, P. Załecki, M. Paprocka, A Wiedłocha, C. Goupille, and C. Kieda. 2003. IL-7 receptor is present on human microvascular endothelial cells. Immunol. Lett. 86: 163-168. (Pubitemid 36324277)
58. Pillai, M., B. Torok-Storb, and M. Iwata. 2004. Expression and function of IL-7 receptors in marrow stromal cells. Leuk. Lymphoma 45: 2403-2408. (Pubitemid 40081182)
59. Mehler, M. F, R. Rozental, M. Dougherty, D. C. Spray, and J. A. Kessler. 1993. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362: 62-65. (Pubitemid 23087290)
60. Walline, C. C, S. Kanakasabai, and J. J. Bright. 2011. IL-7Ra confers susceptibility to experimental autoimmune encephalomyelitis. Genes Immun. 12: 1-14.
61. Alves, N. L., E. M. van Leeuwen, I. A. Derks, and R. A. van Lier. 2008. Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling. J. Immunol. 180: 5201-5210.
62. Mackall, C. L., T J. Fry, and R. E. Gress. 2011. Harnessing the biology of IL-7 for therapeutic application. Nat. Rev. Immunol. 11: 330-342.
63. Petermann, F, and T Korn. 2011. Cytokines and effector T cell subsets causing autoimmune CNS disease. FEBS Lett. 585: 3747-3757.
64. Young, H. A, and K. J. Hardy. 1995. Role of interferon-g in immune cell regulation. J. Leukoc. Biol. 58: 373-381.
65. Fossiez, F, O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603. (Pubitemid 26193037)
66. Akassoglou, K., J. Bauer, G. Kassiotis, M. Pasparakis, H. Lassmann, G. Kollias, and L. Probert. 1998. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogli-opathy. Am. J. Pathol. 153: 801-813. (Pubitemid 28419033)
67. Holtmann, M. H., and M. F Neurath. 2004. Differential TNF-signaling in chronic inflammatory disorders. Curr. Mol. Med. 4: 439-444. (Pubitemid 38787012)
68. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65. (Pubitemid 36511832)
69. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
70. Renno, T., M. Krakowski, C. Piccirillo, J. Y. Lin, and T. Owens. 1995. TNF-a expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines. J. Immunol. 154: 944-953.
71. Lieberman, A. P., P. M. Pitha, H. S. Shin, and M. L. Shin. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipo-polysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA 86: 6348-6352. (Pubitemid 19210649)